Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
Clover Health to Participate in Upcoming Investor Conferences
-
Clover Health (CLOV) PT Raised to $2.50 at Canaccord Genuity
-
Clover Health Reports Second Quarter 2024 Financial Results; Improves Full-Year Guidance on Strong Performance
-
Clover Health to Participate in Upcoming 2024 KeyBanc Technology Leadership Forum and Canaccord Genuity 44th Annual Growth Conference
-
Clover Health Reports Third Quarter 2023 Results; Highlights Continued Improvement in Financial Performance and Improved 2023 Guidance
-
Clover Health Reports Strong Second Quarter 2023 Results; Highlights Improved Financial Performance and Guidance Ranges
-
Clover Health to Present at Canaccord Genuity 43rd Annual Growth Conference and 2023 Wells Fargo Healthcare Conference
-
Clover Health to Present at Canaccord Genuity 42nd Annual Growth Conference on August 10, 2022
-
Clover Announces Closing of Public Offering of Class A Common Stock
-
Clover Health Investments (CLOV) Prices Upsized 52.17M Share Offering at $5.75/sh
-
Clover Health Investments, Corp. Announces Pricing of $300 Million Upsized Public Offering of Class A Common Stock
-
Clover Health (CLOV) Stock Dinged 9% on 35M Share Stock Offering
-
Clover Health Investments (CLOV) Announces 35M Share Proposed Public Offering of Class A Common Stock
-
Clover Health Investments, Corp. Announces Proposed Public Offering of Class A Common Stock
